Compounds > alendronate

alendronate and technetium tc 99m medronate

alendronate has been researched along with technetium tc 99m medronate in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (28.57)	18.2507
2000's	2 (28.57)	29.6817
2010's	3 (42.86)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Koyano, H; Schimizu, T; Shishiba, Y	1
Arteaga de Murphy, C; Meléndez-Alafort, L; Montoya-Molina, CE; Sepúlveda-Méndez, J	1
Carrasquillo, JA; Dahut, W; Dyer, V; Figg, WD; Whatley, M	1
Hayashi, F; Takao, S; Takata, S; Yasui, N; Yoshida, S	1
Butt, R; Butt, ST; Fatima, S; Irfan, J; Jameel, G; Nasir, W	1
Iwasaki, A; Matsui, Y; Minami, Y; Miyake, M; Ohbayashi, Y; Sawai, F	1
Dong, K; Lou, J; Wen, G; Zhang, Y	1

Trials

1 trial(s) available for alendronate and technetium tc 99m medronate

Article	Year
Early monitoring of osteoporosis treatment response by technetium-99m-methylene diphosphonate bone scan. Nuclear medicine communications, 2017, Volume: 38, Issue:10 Topics: Aged; Alendronate; Bone Density; Female; Femur Neck; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis; Technetium Tc 99m Medronate; Time Factors; Treatment Outcome; Whole Body Imaging	2017

Other Studies

6 other study(ies) available for alendronate and technetium tc 99m medronate

Article	Year
The bisphosphonate dilemma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:4 Topics: Alendronate; Bone and Bones; Bone Neoplasms; Clodronic Acid; Diphosphonates; False Negative Reactions; Female; Humans; Hypercalcemia; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging; Technetium Tc 99m Medronate	1995
Radiopharmacokinetic data for 99mTc-ABP--a new radiopharmaceutical for bone scanning: comparison with 99mTc-MDP. Nuclear medicine and biology, 1997, Volume: 24, Issue:1 Topics: Adult; Alendronate; Animals; Area Under Curve; Bone and Bones; Female; Half-Life; Humans; Male; Mice; Organotechnetium Compounds; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Technetium Tc 99m Medronate; Tissue Distribution	1997
Alendronate does not interfere with 99mTc-methylene diphosphonate bone scanning. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:9 Topics: Aged; Alendronate; Bone Neoplasms; Humans; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate	2001
Therapeutic effects of one-year alendronate treatment in three cases of osteoporosis with parietal thinning of skull. The journal of medical investigation : JMI, 2008, Volume: 55, Issue:3-4 Topics: Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Female; Humans; Male; Osteoporosis; Parietal Bone; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Time Factors	2008
Polyostotic Paget's disease. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2012, Volume: 22, Issue:7 Topics: Aged; Alendronate; Alkaline Phosphatase; Biopsy; Bone Density Conservation Agents; Humans; Male; Osteitis Deformans; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tibia; Treatment Outcome	2012
Adjunct teriparatide therapy with monitoring of bone turnover markers and bone scintigraphy for bisphosphonate-related osteonecrosis of the jaw. Oral surgery, oral medicine, oral pathology and oral radiology, 2013, Volume: 115, Issue:4 Topics: Acid Phosphatase; Aged; Alendronate; Alkaline Phosphatase; Amino Acids; Biomarkers; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Regeneration; Bone Resorption; Collagen Type I; Female; Follow-Up Studies; Humans; Isoenzymes; Mandible; Mandibular Diseases; Osteocalcin; Osteogenesis; Peptide Fragments; Peptides; Procollagen; Radionuclide Imaging; Radiopharmaceuticals; Tartrate-Resistant Acid Phosphatase; Technetium Tc 99m Medronate; Teriparatide	2013